ID: ALA1939710

Max Phase: Preclinical

Molecular Formula: C44H58N16O8

Molecular Weight: 939.05

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  CN(CC[C@H](N)C(=O)NCc1ccccc1-c1ccccc1CNC(=O)[C@@H](N)CCN(C)C[C@H]1O[C@@H](n2cnc3c(N)ncnc32)[C@H](O)[C@@H]1O)C[C@H]1O[C@@H](n2cnc3c(N)ncnc32)[C@H](O)[C@@H]1O

Standard InChI:  InChI=1S/C44H58N16O8/c1-57(17-29-33(61)35(63)43(67-29)59-21-55-31-37(47)51-19-53-39(31)59)13-11-27(45)41(65)49-15-23-7-3-5-9-25(23)26-10-6-4-8-24(26)16-50-42(66)28(46)12-14-58(2)18-30-34(62)36(64)44(68-30)60-22-56-32-38(48)52-20-54-40(32)60/h3-10,19-22,27-30,33-36,43-44,61-64H,11-18,45-46H2,1-2H3,(H,49,65)(H,50,66)(H2,47,51,53)(H2,48,52,54)/t27-,28-,29+,30+,33+,34+,35+,36+,43+,44+/m0/s1

Standard InChI Key:  MKXHZNUFJMPTAS-GOGOWKJJSA-N

Associated Targets(non-human)

metJ Met repressor (40 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 939.05Molecular Weight (Monoisotopic): 938.4624AlogP: -2.03#Rotatable Bonds: 19
Polar Surface Area: 355.34Molecular Species: BASEHBA: 22HBD: 10
#RO5 Violations: 3HBA (Lipinski): 24HBD (Lipinski): 14#RO5 Violations (Lipinski): 3
CX Acidic pKa: 12.16CX Basic pKa: 8.69CX LogP: -2.90CX LogD: -4.99
Aromatic Rings: 6Heavy Atoms: 68QED Weighted: 0.04Np Likeness Score: 0.04

References

1. Joce C, White R, Stockley PG, Warriner S, Turnbull WB, Nelson A..  (2012)  Design, synthesis and in vitro evaluation of novel bivalent S-adenosylmethionine analogues.,  22  (1): [PMID:22137339] [10.1016/j.bmcl.2011.11.017]

Source